SF
PCRX icon

Synovus Financial’s Pacira BioSciences PCRX Stock Holding History

Synovus Financial’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-19
Closed -$1K – 1974
2020
Q1 		$1K Sell
19
-46
-71% -$1.91K ﹤0.01% 2053
2019
Q4 		$3K Hold
65
– – ﹤0.01% 1387
2019
Q3 		$2K Hold
65
– – ﹤0.01% 1394
2019
Q2 		$3K Hold
65
– – ﹤0.01% 1296
2019
Q1 		$2K Hold
65
– – ﹤0.01% 1354
2018
Q4 		$3K Hold
65
– – ﹤0.01% 1273
2018
Q3 		$3K Hold
65
– – ﹤0.01% 1302
2018
Q2 		$2K Hold
65
– – ﹤0.01% 1199
2018
Q1 		$2K Buy
+65
New +$2.31K ﹤0.01% 1163
2017
Q2 		– Sell
-65
Closed -$3K – 1020
2017
Q1 		$3K Hold
65
– – ﹤0.01% 1049
2016
Q4 		$2K Buy
+65
New +$2.17K ﹤0.01% 1020
2015
Q2 		– Sell
-180
Closed -$16K – 1016
2015
Q1 		$16K Hold
180
– – ﹤0.01% 802
2014
Q4 		$16K Buy
+180
New +$17K ﹤0.01% 805

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return